IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), a leading medical cannabis company, is set to announce its operational and financial results for the second quarter of 2024 on August 14, 2024. The Company will release the results before the market opens and will host a zoom web conference at 9:00am ET on the same day to discuss the findings and address questions from the investment community.
Investors are invited to register for the conference call by visiting the provided link. Upon registration, all relevant information will be sent to participants. For those unable to join the live session, a recording of the call will be made available on the Company’s website within 24 hours.
IM Cannabis Corp. is an international cannabis company that focuses on providing premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company’s transnational ecosystem is powered by a unique data-driven approach and a globally sourced product supply chain.
In Israel, IM Cannabis Corp. operates through Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs to ensure the safe delivery and quality control of its products throughout the entire value chain.
In Germany, the Company operates through Adjupharm GmbH, distributing cannabis to pharmacies for medical cannabis patients.
With a commitment to responsible growth and compliance with strict regulatory environments, IM Cannabis Corp. aims to become a global high-quality cannabis player, amplifying its commercial and brand power.
For further information, please contact Anna Taranko, Director Investor & Public Relations at a.taranko@imcannabis.de or +49 157 80554338.